Previous close | 18.30 |
Open | 18.63 |
Bid | 18.79 x 300 |
Ask | 18.85 x 300 |
Day's range | 17.91 - 19.09 |
52-week range | 9.50 - 19.09 |
Volume | |
Avg. volume | 1,212,372 |
Market cap | 3.514B |
Beta (5Y monthly) | 1.63 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The average of price targets set by Wall Street analysts indicates a potential upside of 28.6% in Avadel (AVDL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]
Avadel Pharmaceuticals plc ( NASDAQ:AVDL ) is possibly approaching a major achievement in its business, so we would...